Logo | Name | Σ | ||
---|---|---|---|---|
Illumina For Startups Illumina for Startups supporting genomics and multi-omics startups across the globe. Illumina for Startups Network aims to inspire the creation, funding, and growth of genomics and multi-omics startups across the globe. It is designed for the entrepreneurial ecosystem and focused on building connections, strengthening community, and advancing breakthrough genomics applications. Current Illumina for Startups initiatives include Startups Grants for founders to work with Illumina sites to run proof-of-concept sequencing experiments. For more information visit https://www.illumina.com/company/illumina-for-startups.html Past initiatives include Illumina Accelerator, company creation engine co-located with Illumina research and development sites in San Francisco Bay Area and Cambridge, UK. Illumina Accelerator … Sectors: Biotechnology Startup accelerator & VC | 917 | 456 | 155 | |
European Bioinformatics Institute | EMBL-EBI Powering big data for the life sciences Working at EMBL-EBI gives you the opportunity to focus your energy and skills on something that really matters: using technology to contribute to discoveries that benefit humankind. We empower researchers everywhere to realise the potential of ‘big data’ in biology, and build sophisticated tools for exploring life at the atomic level. Databases, Bioinformatics training, Industry, EMBL International PhD Programme, Computational biology, Software development, User experience design, Web development, Cloud technology, Data analysis, Bioinformatics, Web production, Data infrastructure, Computational research, Software, Life sciences, Open data, Open access, COVID-19 data, and Data science Sectors: Research | 167 | 116 | 48 | |
AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: Pharmaceutical | 3764 | 2605 | 203 | |
UK Research and Innovation Transforming Tomorrow Together UK Research and Innovation (UKRI) is the public sector organisation that invests £8 billion annually to support the entire research and innovation system. We strive for a society powered and empowered by research and innovation, with economic, social, environmental and cultural benefits for all. We invest in people, places, ideas, innovation and impacts, empowering researchers, innovators and entrepreneurs to turn the many challenges we all face into opportunities, driving up prosperity and wellbeing across the UK and globally. The impacts of our work are felt right across society. We enrich lives by increasing our understanding of ourselves … Sectors: Public business cluster | 4037 | 2857 | 695 | |
ZEISS Group We are a global technology leader advancing the world of optics. #SeeingBeyond ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 10 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2023). With around 43,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 30 September 2023). Founded in 1846 in Jena, the … Sectors: Optical systems | 375 | 334 | 7 | |
MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: Pharmaceutical | 2103 | 1852 | 189 | |
Société des Neurosciences [Automatic translation follows] Our mission: to promote the development of research in Neuroscience. Coordinator of #BrainWeek The Neuroscience Society is a non-profit scientific association, governed by the law of 1901. Its aim is - to promote the development of research in all areas of neuroscience. - to encourage interactions between researchers from all backgrounds. - to contribute to the animation and development of scientific activity, the dissemination of scientific knowledge in the context of education, the training of young researchers and public information. The Neuroscience Society supports young researchers by awarding them a number of Prizes. It coordinates BrainWeek every … Sectors: NGO, Think Tank | 126 | 60 | 36 | |
Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we … Sectors: Biotechnology | 692 | 481 | 48 | |
ILL - Institut Laue Langevin The Europeans's leading facility in neutron science & technology The Institut Laue-Langevin is an international research centre at the leading edge of neutron science and technology. As the world’s flagship centre for neutron science, the ILL provides scientists with a very high flux of neutrons feeding some 40 state-of-the-art instruments, which are constantly being developed and upgraded. As a service institute ILL makes its facilities and expertise available to visiting scientists. Every year, about 1400 researchers from over 40 countries visit the ILL and 640 experiments selected by a scientific review committee are performed. Research focuses primarily on fundamental science … Sectors: Research | 296 | 88 | 163 | |
Institut Curie [Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospitals. Founded in 1909 on a model designed by Marie Curie and still avant-garde, "from fundamental research to innovative care", the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Care The Institut Curie Hospital Group is a reference center for breast cancer, eye tumors and pediatric cancers in particular. Research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians and doctors are mobilizing … Sectors: Health | 892 | 727 | 139 | |
Google A problem isn't truly solved until it's solved for all. Googlers build products that help create opportunities for everyone, whether down the street or across the globe. Bring your insight, imagination and a healthy disregard for the impossible. Bring everything that makes you unique. Together, we can build for everyone. Check out our career opportunities at goo.gle/3DLEokh search, ads, mobile, android, online video, apps, machine learning, virtual reality, cloud, hardware, artificial intelligence, youtube, and software Sectors: IT services | 25344 | 19780 | 1090 | |
BASF We create chemistry for a sustainable future At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €68.9 billion in 2023. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Credits: https://www.basf.com/en/tools/legal/credits.html Data … | 4030 | 2524 | 466 |